Prevymis (letermovir) concentrate for solution for infusion - Essential to administer through sterile 0.2 micron or 0.22 micron polyethersulfone (PES) in-line filter
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Prevymis
|
| Active substance |
Letermovir
|
| Therapeutic area (MeSH) |
Cytomegalovirus Infections
|
| Procedure number |
II/16/G
|
| Regulatory outcome |
Variation
|
| Human ATC code |
J05
|